These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 15167153)

  • 1. Cost-utility and cost-benefit analyses: how did we get here and where are we going?
    Moayyedi P; Mason J
    Eur J Gastroenterol Hepatol; 2004 Jun; 16(6):527-34. PubMed ID: 15167153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-effectiveness analysis and incremental cost-effectiveness ratios: uses and pitfalls.
    Bambha K; Kim WR
    Eur J Gastroenterol Hepatol; 2004 Jun; 16(6):519-26. PubMed ID: 15167152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quality of life and health economics: where is the link?
    Jönsson B
    Scand J Gastroenterol Suppl; 1996; 221():33-6. PubMed ID: 9110396
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Accounting for future costs in medical cost-effectiveness analysis.
    Meltzer D
    J Health Econ; 1997 Feb; 16(1):33-64. PubMed ID: 10167344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-benefit analyses in the health-care literature: don't judge a study by its label.
    Zarnke KB; Levine MA; O'Brien BJ
    J Clin Epidemiol; 1997 Jul; 50(7):813-22. PubMed ID: 9253393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implications of basing health-care resource allocations on cost-utility analysis in the presence of externalities.
    Labelle RJ; Hurley JE
    J Health Econ; 1992 Oct; 11(3):259-77. PubMed ID: 10122539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Economic analysis in dermatology.
    Ellis CN; Reiter KL; Wheeler JR; Fendrick AM
    J Am Acad Dermatol; 2002 Feb; 46(2):271-83. PubMed ID: 11807441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An overview of economic analysis for the practising gastroenterologist and hepatologist.
    Provenzale D
    Eur J Gastroenterol Hepatol; 2004 Jun; 16(6):513-7. PubMed ID: 15167151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The importance of patient preferences for comorbidities in cost-effectiveness analyses.
    Harris RA; Nease RF
    J Health Econ; 1997 Feb; 16(1):113-9. PubMed ID: 10167342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Economic considerations for the hepatologist.
    Provenzale D
    Hepatology; 1999 Jun; 29(6 Suppl):13S-17S. PubMed ID: 10386077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PPD-QALY-an index for cost-effectiveness in orthopedics: providing essential information to both physicians and health care policy makers for appropriate allocation of medical resources.
    Dougherty CP; Howard T
    Sports Med Arthrosc Rev; 2013 Sep; 21(3):169-73. PubMed ID: 23924750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The cost-effectiveness challenge: is it worth it?
    Knapp M
    Alzheimers Res Ther; 2015 Jan; 7(1):10. PubMed ID: 27391601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimal allocation of resources over health care programmes: dealing with decreasing marginal utility and uncertainty.
    Al MJ; Feenstra TL; Hout BA
    Health Econ; 2005 Jul; 14(7):655-67. PubMed ID: 15678518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Methods of comparative economic evaluations of therapies and for rational allocation of resources across sectors of health care systems - introduction, advantages, risks].
    Wasem J; Hessel F; Kerim-Sade C
    Psychiatr Prax; 2001 Jul; 28 Suppl 1():S12-20. PubMed ID: 11533902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Accounting for the missing opportunity costs in incremental cost-outcome analysis.
    Oliver A
    Appl Health Econ Health Policy; 2002; 1(4):191-6. PubMed ID: 14619248
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quality-adjusted life-years lack quality in pediatric care: a critical review of published cost-utility studies in child health.
    Griebsch I; Coast J; Brown J
    Pediatrics; 2005 May; 115(5):e600-14. PubMed ID: 15867026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Costing and perspective in published cost-effectiveness analysis.
    Neumann PJ
    Med Care; 2009 Jul; 47(7 Suppl 1):S28-32. PubMed ID: 19536023
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The economic evaluation of health care.
    Haas M; Hall J
    Health Inf Manag; 1998 Dec-1999 Feb; 28(4):169-72. PubMed ID: 10387363
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A second opinion. Cost-utility analysis and varying preferences for health.
    Mooney G; Jan S
    Health Policy; 1997 Sep; 41(3):201-3; discussion 203-5. PubMed ID: 10170089
    [No Abstract]   [Full Text] [Related]  

  • 20. Health economic methods: cost-minimization, cost-effectiveness, cost-utility, and cost-benefit evaluations.
    Higgins AM; Harris AH
    Crit Care Clin; 2012 Jan; 28(1):11-24, v. PubMed ID: 22123096
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.